Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients having the clinical manifestation of Amavata (RA) according to Ayurvedic classics - SANDHISHOOL (PAIN), SHOTH (SWELLING), SPARSHASAHTA (TENDERNESS) and STABDHATA (STIFFNESS),Vrishichikadansavata vedana (pain like scorpion sting), Agnimandya (poor digestion) , Aruchi(anorexia), Gaurav(Feeling of heaviness of body),Utsaha Hani(lack of interest),Mukha vairasya(Perverted taste) or having positive RA factor. 2)The 2010 American College of Rheumatology/ European League Against Rheumatism classification criteria for rheumatoid arthritis Score. 3)Classification criteria for RA (score-based algorithm: add score of categories Aâ??D; a score of 6/10 is needed for classification of a patient as having definite RA). A. Joint involvement â?ª 1 large joint 0 â?ª 2-10 large joints 1 â?ª 1-3 small joints (with or without involvement of large joints) 2 â?ª 4-10 small joints (with or without involvement of large joints) 3 â?ª >10 joints (at least 1 small joints) 5 B. Serology (at least 1 test result is needed for classification) â?ª Negative RF and negative ACPA 0 â?ª Low-positive RF or low-positive ACPA 2 â?ª High-positive RF or high-positive ACPA 3 C. Acute-phase reactants (at least 1 test result is needed for classification) â?ª Normal CRP and normal ESR 0 â?ª Abnormal CRP or abnormal ESR 1 D. Duration of symptoms â?ª â?ª >6 weeks 1 4) Patients willing to participate in the research study
Exclusion criteria
Exclusion criteria: 1) Patients with other systemic complications of RA like RHD, Rheumatic fever, pleural â?? pericardial disease. 2) Patients with poorly controlled Hypertension ( >160/100 mm of Hg) 3) Patients with Diabetes Mellitus {B.S. (F) > 126 mg% and / or B.S. (2 hr. PP) >200 mg% OR HbA1c > 6.5%} 4) Patients diagnosed with other arthritis like gouty arthritis, tuberculous arthritis, etc. 5) Patients who are unable to walk without support and / or confined to wheel chair. 6) H/o hypersensitivity to any of the trial drugs or their ingredients. 7) Patients on prolonged ( > 6 weeks) medication with antidepressants, anticholinergic, etc. or any other drugs that may have an influence on the outcome of the study. 8) Pregnant / lactating woman. 9) Patients who have completed participation in any other clinical trial during the past 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Reduction in VAS Score. 2)Providing the Vednahara (analgesic) effect management of Amavata (RA) with Ayurvedic shaman chikitsa.Timepoint: 55 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement in the quality of life with the help of questionnaires for scaling of W.H.O quality of life.Timepoint: 55 Days | — |
Countries
India
Contacts
All India Institute of Ayurveda